Skip to content

13F-HR filed by Column Group LLC

Column Group LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-13, with 7 holding rows worth $150,609,187.

Accession
0000950123-23-010234
Filed
2023-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2023

A holdings report, 7 entries on the cover page, a total value of $150,609,187 stated on the cover page (in dollars after the unit check, H1), rows summing to $150,609,187 with VALUE read as dollars as filed, 13F file number 028-20797. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
RAPT THERAPEUTICS INC75382E109COM2,680,621$44,551,921dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock1,230,641$34,064,143dollars as filed
TENAYA THERAPEUTICS INC87990A106COM9,400,290$23,970,740dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM3,568,181$21,587,495dollars as filed
NGM BIOPHARMACEUTICALS INC62921N105COM18,136,735$19,406,306dollars as filed
Surrozen, Inc.86889P109COM9,414,795$4,613,250dollars as filed
EFFECTOR THERAPEUTICS INC28202V108COM4,026,224$2,415,332dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-23-010234this filing2023-11-13acceptance time not in the bulk data set